Advanced B-cell NHL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma (NCT02253992) | Bristol-Myers Squibb | 2014-09-29 |
Track Advanced B-cell NHL automatically
Every clearance here is in the API, with alerts when new ones post.